Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    June 2025
  1. LIU J, Xu J, Sun R, Wang X, et al
    MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia progression via inducing MYCT1 degradation.
    Oncogene. 2025 Jun 18. doi: 10.1038/s41388-025-03464.
    PubMed     Abstract available


  2. LI YQ, Liu D, Wang LL, Shao YL, et al
    WTAP-mediated m(6)A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML.
    Oncogene. 2025;44:1504-1516.
    PubMed     Abstract available


  3. XIE Y, Zhao R, Zheng Y, Li Y, et al
    Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import.
    Oncogene. 2025;44:1646-1661.
    PubMed     Abstract available


    May 2025
  4. YAO L, Zhang X, Li X, Xu J, et al
    circAFF2 promotes the development of AML by binding to PML mRNA.
    Oncogene. 2025;44:1234-1244.
    PubMed     Abstract available


    March 2025
  5. ZHANG L, Wang X, Hu D, Li S, et al
    SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression.
    Oncogene. 2025 Mar 27. doi: 10.1038/s41388-025-03350.
    PubMed     Abstract available


    February 2025
  6. TIAN X, Zhang L, Xiang G, Tang Y, et al
    Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation.
    Oncogene. 2025 Feb 22. doi: 10.1038/s41388-025-03309.
    PubMed     Abstract available


  7. VALIMA E, Varis V, Bureiko K, Lempiainen JK, et al
    SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells.
    Oncogene. 2025 Feb 14. doi: 10.1038/s41388-025-03305.
    PubMed     Abstract available


  8. ZHANG J, Zhai J, Wong CC, Chen H, et al
    Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
    PubMed    


    November 2024
  9. DUAN C, Lin X, Zou W, He Q, et al
    Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03215.
    PubMed     Abstract available


  10. ZHANG C, Hao T, Bortoluzzi A, Chen MH, et al
    Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential.
    Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197.
    PubMed     Abstract available


    August 2024
  11. SERGIO I, Varricchio C, Patel SK, Del Gaizo M, et al
    Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL.
    Oncogene. 2024;43:2535-2547.
    PubMed     Abstract available


    June 2024
  12. WANG G, Zhang W, Ren J, Zeng Y, et al
    The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
    Oncogene. 2024;43:1900-1916.
    PubMed     Abstract available


    April 2024
  13. SAFFERTHAL C, Rohde K, Fulda S
    Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022.
    PubMed    


    March 2024
  14. GUO T, Wang Y, Sun X, Hou S, et al
    Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1.
    Oncogene. 2024 Mar 21. doi: 10.1038/s41388-024-03006.
    PubMed     Abstract available


    December 2023
  15. LEI H, Xu H, Yang L, Wang Y, et al
    USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia.
    Oncogene. 2023 Dec 16. doi: 10.1038/s41388-023-02921.
    PubMed    


  16. NOURA M, Matsuo H, Yasuda T, Tsuzuki S, et al
    Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02913.
    PubMed     Abstract available


  17. DI MAMBRO A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al
    SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
    Oncogene. 2023;42:3670-3683.
    PubMed     Abstract available


    November 2023
  18. ERKNER E, Hentrich T, Schairer R, Fitzel R, et al
    The ROR?/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
    Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02903.
    PubMed     Abstract available


    October 2023
  19. XIE X, Zhang W, Zhou X, Xu B, et al
    Low doses of IFN-gamma maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
    Oncogene. 2023 Oct 23. doi: 10.1038/s41388-023-02874.
    PubMed     Abstract available


    September 2023
  20. MA H, Cui J, Liu Z, Fang W, et al
    Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia.
    Oncogene. 2023 Sep 26. doi: 10.1038/s41388-023-02848.
    PubMed     Abstract available


  21. PAWLIKOWSKA P, Delestre L, Gregoricchio S, Oppezzo A, et al
    FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
    Oncogene. 2023;42:2764-2775.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.